BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 33767371)

  • 1. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications.
    Yao L; Yin H; Hong M; Wang Y; Yu T; Teng Y; Li T; Wu Q
    Leukemia; 2021 May; 35(5):1243-1257. PubMed ID: 33767371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
    Markouli M; Strepkos D; Piperi C
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic programming contributes to development of drug resistance in hematological malignancies.
    Wang QY; Zhong H
    Front Biosci (Landmark Ed); 2015 Jan; 20(4):728-42. PubMed ID: 25553475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA methylation landscape of hematological malignancies: an update.
    Blecua P; Martinez-Verbo L; Esteller M
    Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
    Zhao A; Zhou H; Yang J; Li M; Niu T
    Signal Transduct Target Ther; 2023 Feb; 8(1):71. PubMed ID: 36797244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health.
    Xavier MJ; Roman SD; Aitken RJ; Nixon B
    Hum Reprod Update; 2019 Sep; 25(5):518-540. PubMed ID: 31374565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A primer for epigenetics of hematological malignancies].
    Nakajima H
    Rinsho Ketsueki; 2016; 57(10):1835-1844. PubMed ID: 27725578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel epigenetic therapies in hematological malignancies: Current status and beyond.
    Gallipoli P; Huntly BJP
    Semin Cancer Biol; 2018 Aug; 51():198-210. PubMed ID: 28782607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EHA scientific workshop report: the role of epigenetics in hematological malignancies.
    Jost E; Galm O
    Epigenetics; 2007; 2(2):71-9. PubMed ID: 17965605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in epigenetic therapeutics with focus on solid tumors.
    Jin N; George TL; Otterson GA; Verschraegen C; Wen H; Carbone D; Herman J; Bertino EM; He K
    Clin Epigenetics; 2021 Apr; 13(1):83. PubMed ID: 33879235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy.
    Shafabakhsh R; Aghadavod E; Ghayour-Mobarhan M; Ferns G; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7839-7846. PubMed ID: 30515789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
    Fratta E; Montico B; Rizzo A; Colizzi F; Sigalotti L; Dolcetti R
    Oncotarget; 2016 Aug; 7(35):57327-57350. PubMed ID: 27329599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic therapy in hematological cancers.
    Dimopoulos K; Grønbaek K
    APMIS; 2019 May; 127(5):316-328. PubMed ID: 30859683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Modifications in Aging: The Underlying Mechanisms and Implications.
    Wang Y; Yuan Q; Xie L
    Curr Stem Cell Res Ther; 2018; 13(2):125-135. PubMed ID: 28820059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular basis of hematological malignancies].
    Kitamura T; Inoue D; Nakahara F; Okochi N; Kato N; Togami K; Uchida T; Kagiyama Y; Kawabata KC; Nagase R; Horikawa S; Hayashi K; Saika M; Izawa K; Oki T; Chiba S; Harada Y; Harada H; Kitaura J
    Rinsho Ketsueki; 2014 Oct; 55(10):1715-23. PubMed ID: 25297732
    [No Abstract]   [Full Text] [Related]  

  • 17. Epigenetically-targeted therapies for the treatment of hematological malignancies.
    Georgiou E; Kouidou S
    Curr Med Chem; 2011; 18(12):1757-64. PubMed ID: 21466475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory methods to decipher epigenetic signatures: a comparative review.
    Halabian R; Valizadeh Arshad ; Ahmadi A; Saeedi P; Azimzadeh Jamalkandi S; Alivand MR
    Cell Mol Biol Lett; 2021 Nov; 26(1):46. PubMed ID: 34763654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation and Histone Modification in Dental-derived Mesenchymal Stem Cells.
    Zeng B; Liu G; Huang J
    Stem Cell Rev Rep; 2022 Dec; 18(8):2797-2816. PubMed ID: 35896859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic dysregulation in hematological malignancies.
    Iwama A
    Int J Hematol; 2017 Jan; 105(1):5-6. PubMed ID: 27822916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.